Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall, Healius receives $1.52 billion takeover offer
WEED WEEK: Wellnex teams up with Chemist Warehouse for new cannabis products
Mach 7 positions for enterprise imaging uptake solving tomorrow’s problems with today’s software
Why growth is a positive for the ASX medical imaging sector
ASX Health Stocks: TGA’s new ruling has cannabis stocks rushing toward psychedelics – LGP is one of them
ASX Health Stocks: Firebrick to start Phase 3 trial on common cold spray, MGC Pharma surges 30pc on FDA listing
A huge leap for MGC Pharma as Covid-19 spray ArtemiC is included in the FDA’s National Drug Code Database
Prescient Therapeutics hopes to accelerate bid for US FDA study approval for targeted therapy PTX-100
ASX Health Stocks: Healius gets takeover offer from company less than half its size
ScoPo’s Powerplays: ASX health stocks drop as Neuren surges 60% on US FDA approval
ASX Health Stocks: Neurotech says NTI164 works well in 11 autistic children after 52 weeks of treatment
Incannex to open psychedelic clinic’s business with leading Australian experts
ASX Health Stocks: High fives as Telix gets expanded FDA approval, Prescient’s PTX-100 returns good results
Incannex’s interim data predicts a statistically significant benefit for psilocybin therapy over placebo when treating anxiety, FDA IND application now in sight
Wellnex Life joins forces with Chemist Warehouse to enter SAS-B medicinal cannabis market
ASX Health Stocks: Patrys’ drug exhibits cancer lethality, US Patent Office says yes to Alterity
Could immunotherapy replace chemo? Here’s one stock that could rise 5x according to broker
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
